Research Study

A Registry of Patients With Moderate to Severe Chronic Plaque Psoriasis in Canada and Latin AmErica (LACan)
Principal Investigator 
Vincent C. Ho

Overview

Body Locations and Systems 
Psoriasis
ClinicalTrials.gov# 
NCT02786186
Status 
Recruiting
Study Start/End 
Feb 11, 2016 to Oct 30, 2020
Locations 
Vancouver General Hospital
Name/Title 
Satvir Dhoot, Clinical Trial Coordinator
Phone 
604-875-5296
Email Address 
satvir.dhoot@ubc.ca
Purpose of Study 

The main purpose of the current study will be to provide real - world evidence regarding the safety and effectiveness of secukinumab in the management of patients with moderate to severe chronic plaque psoriasis.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.